Literature DB >> 24461366

Alterations of Ca²⁺-responsive proteins within cholinergic neurons in aging and Alzheimer's disease.

David Riascos1, Alexander Nicholas2, Ravand Samaeekia1, Rustam Yukhananov3, M-Marsel Mesulam1, Eileen H Bigio1, Sandra Weintraub1, Ling Guo1, Changiz Geula4.   

Abstract

The molecular basis of selective neuronal vulnerability in Alzheimer's disease (AD) remains poorly understood. Using basal forebrain cholinergic neurons (BFCNs) as a model and immunohistochemistry, we have demonstrated significant age-related loss of the calcium-binding protein calbindin-D(28K) (CB) from BFCN, which was associated with tangle formation and degeneration in AD. Here, we determined alterations in RNA and protein for CB and the Ca(2+)-responsive proteins Ca(2+)/calmodulin-dependent protein kinase I (CaMKI), growth-associated protein-43 (GAP43), and calpain in the BF. We observed progressive downregulation of CB and CaMKI RNA in laser-captured BFCN in the normal-aged-AD continuum. We also detected progressive loss of CB, CaMKIδ, and GAP43 proteins in BF homogenates in aging and AD. Activated μ-calpain, a calcium-sensitive protease that degrades CaMKI and GAP43, was significantly increased in the normal aged BF and was 10 times higher in AD BF. Overactivation of μ-calpain was confirmed using proteolytic fragments of its substrate spectrin. Substantial age- and AD-related alterations in Ca(2+)-sensing proteins most likely contribute to selective vulnerability of BFCN to degeneration in AD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal forebrain; CaMKI; Calbindin-D(28K); Calpain; Cholinergic system; GAP43; Proteolysis

Mesh:

Substances:

Year:  2013        PMID: 24461366      PMCID: PMC3961506          DOI: 10.1016/j.neurobiolaging.2013.12.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  61 in total

Review 1.  The cholinergic innervation of the human cerebral cortex.

Authors:  M Marsel Mesulam
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

Review 2.  Protein kinases in the brain.

Authors:  A C Nairn; H C Hemmings; P Greengard
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 3.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

4.  Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones.

Authors:  K Goslin; D J Schreyer; J H Skene; G Banker
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

5.  Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation.

Authors:  H E Scharfman; P A Schwartzkroin
Journal:  Science       Date:  1989-10-13       Impact factor: 47.728

6.  Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo.

Authors:  Zsolt Molnár; Katalin Soós; Imre Lengyel; Botond Penke; Viktor Szegedi; Dénes Budai
Journal:  Neuroreport       Date:  2004-07-19       Impact factor: 1.837

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

8.  The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures.

Authors:  Sanjay C Keswani; Brian Rosenberg; Ahmet Hoke
Journal:  J Neurosci Methods       Date:  2004-07-30       Impact factor: 2.390

9.  Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice.

Authors:  William B J Cafferty; Natalie J Gardiner; Partha Das; Jin Qiu; Stephen B McMahon; Stephen W N Thompson
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

Review 10.  Pathways towards and away from Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Nature       Date:  2004-08-05       Impact factor: 49.962

View more
  11 in total

1.  Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Bin He; Sarah M Ward; Angela L Guillozet-Bongaarts; Nicholas M Kanaan; Elliott J Mufson; Scott E Counts
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

2.  Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5.

Authors:  Ke Li; Fang-Fang Liu; Chun-Xue He; He-Zhou Huang; Ao-Ji Xie; Fan Hu; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-12-03       Impact factor: 5.590

3.  Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.

Authors:  Saman S Ahmadian; Aras Rezvanian; Melanie Peterson; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  Neurobiol Aging       Date:  2015-09-06       Impact factor: 4.673

4.  Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.

Authors:  Martin Larsson; Grazyna Lietzau; David Nathanson; Claes-Göran Östenson; Carina Mallard; Maria E Johansson; Thomas Nyström; Cesare Patrone; Vladimer Darsalia
Journal:  Biosci Rep       Date:  2016-12-05       Impact factor: 3.840

5.  Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.

Authors:  Sarah C Kelly; Bin He; Sylvia E Perez; Stephen D Ginsberg; Elliott J Mufson; Scott E Counts
Journal:  Acta Neuropathol Commun       Date:  2017-01-21       Impact factor: 7.801

6.  Transient increase in CSF GAP-43 concentration after ischemic stroke.

Authors:  Åsa Sandelius; Nicholas C Cullen; Åsa Källén; Lars Rosengren; Crister Jensen; Vesna Kostanjevecki; Manu Vandijck; Henrik Zetterberg; Kaj Blennow
Journal:  BMC Neurol       Date:  2018-12-07       Impact factor: 2.474

7.  Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.

Authors:  Åsa Sandelius; Erik Portelius; Åsa Källén; Henrik Zetterberg; Uros Rot; Bob Olsson; Jon B Toledo; Leslie M Shaw; Virginia M Y Lee; David J Irwin; Murray Grossman; Daniel Weintraub; Alice Chen-Plotkin; David A Wolk; Leo McCluskey; Lauren Elman; Vesna Kostanjevecki; Manu Vandijck; Jennifer McBride; John Q Trojanowski; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2018-10-12       Impact factor: 21.566

8.  Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.

Authors:  Youmei Xie; Rick B Meeker; Stephen M Massa; Frank M Longo
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

9.  Precuneus-Dominant Degeneration of Parietal Lobe Is at Risk of Epilepsy in Mild Alzheimer's Disease.

Authors:  Andras Horvath; Mate Kiss; Anna Szucs; Anita Kamondi
Journal:  Front Neurol       Date:  2019-08-22       Impact factor: 4.003

Review 10.  Advances in transcriptome analysis of human brain aging.

Authors:  Seokjin Ham; Seung-Jae V Lee
Journal:  Exp Mol Med       Date:  2020-11-26       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.